- NCT00000328
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment III) - 3
Phase 2Withdrawn - NCT00000305
Amphetamine Cocaine Interaction Study - 2
Phase 1Terminated - NCT00000327
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment I(2) - 2
Phase 2Withdrawn - NCT00000192
Neurobiology of Opioid Dependence: 1 - 1
Phase 2Withdrawn - NCT00000193
Neurobiology of Opioid Dependence: 2 - 2
Phase 2Withdrawn - NCT00000194
Neurobiology of Opioid Dependence: 3 - 3
Phase 2Withdrawn - NCT00000195
Neurobiology of Opioid Dependence: 4 - 4
Phase 2Withdrawn - NCT00000196
Neurobiology of Opioid Dependence: 5 - 5
Phase 2Withdrawn - NCT00000197
Propranolol for Treatment of Cocaine Addiction - 2
Phase 2Completed - NCT00000198
Piracetam for Treatment of Cocaine Addiction - 3
Phase 1Completed - NCT00000211
Treatment Efficacy for Drug Abuse and AIDS Prevention - 2
Phase 2Completed - NCT00000199
Piracetam for Treatment of Cocaine Addiction, Phase II - 4
Phase 1Withdrawn - NCT00000200
Cocaine Effects in Humans: Physiology and Behavior - 1
Phase 2Completed - NCT00000201
Pharmacological Modulation of Cocaine Effects - 1
Phase 2Completed - NCT00000202
Buprenorphine Maintenance for Opioid Addicts - 1
Phase 2Completed - NCT00000203
Buprenorphine Maintenance for Opioid Addicts - 2
Phase 2Completed - NCT00000204
Buprenorphine Maintenance for Opioid Addicts - 3
Phase 2Completed - NCT00000205
Buprenorphine Maintenance Protocol - 1
Phase 3Completed - NCT00000358
Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 7
Phase 1Completed - NCT00000357
Buprenorphine Maintenance for Opiate Dependence - 6
Phase 2Completed - NCT00000356
Evaluation of L-alpha-acetylmethadol (LAAM) in Methadone Patients - 5
Phase 2Completed - NCT00000355
Effects of Buprenorphine and Naloxone in Opiate Addicts - 4
Phase 1Completed - NCT00000354
Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 3
Phase 1Completed - NCT00000353
Trial of Buprenorphine/Naloxone for Opiate Dependence - 2
Phase 2Completed - NCT00000352
Effects of Dextromethorphan on Opioid Tolerance in Methadone Patients - 1
Phase 2Completed - NCT00000351
Cognitive Correlates of Substance Abuse, Part 2 - 16
Unknown - NCT00000350
Effects of Stimulant Dependence on Human Striatal Dopamine System - 15
Phase 1Unknown - NCT00000349
Infusion Laboratory: Protocol 5 (Flupenthixol) - 14
Phase 1Unknown - NCT00000348
Infusion Laboratory: Protocol 4 (Dihydrexidine) - 13
Phase 1Unknown - NCT00000347
Risperidone for Treatment of Cocaine Dependence in Outpatients - 12
Phase 2Completed - NCT00000345
Evaluation of Lofexidine for Treatment of Opiate Withdrawal - 10
Phase 1Completed - NCT00000344
Buprenorphine/Naloxone for Treatment of Opiate Dependence - 9
Phase 2Completed - NCT00000342
Risperidone for the Treatment of Cocaine Dependence - 7
Phase 2Completed - NCT00000206
Clinical Rescue Protocol - 2
Phase 2Completed - NCT00000341
Evaluation of Liquid vs. Tablet Buprenorphine - 6
Phase 2Completed - NCT00000340
Pemoline in the Treatment of Stimulant Dependence - 5
Phase 2Withdrawn - NCT00000339
Infusion Laboratory: Protocol 3 (Risperidone) - 4
Phase 1Unknown - NCT00000338
Infusion Laboratory: Protocol 2 (Lisuride) - 3
Phase 1Unknown - NCT00000306
Dextroamphetamine as Adjunct in Cocaine/Opiate Dependent Patients - 3
Phase 2Completed - NCT00000210
Treatment Efficacy for Drug Abuse and AIDS Prevention - 1
Phase 2Completed - NCT00000288
Role of Metabolites in Nicotine Dependence (2) - 5
Phase 2Completed - NCT00000213
IV Cocaine Abuse: A Laboratory Model - 2
Phase 2Completed - NCT00000289
Role of Metabolites in Nicotine Dependence (3) - 6
Phase 2Completed - NCT00000207
Multicenter Clinical Trial of Buprenorphine - 3
Phase 3Completed - NCT00000287
Relapse Patterns in Female Cocaine Users - 4
Completed - NCT00000286
Effects of Nefazodone on Treatment of Female Cocaine Abusers - 3
Phase 2Completed - NCT00000290
Stress Hormones and Human Cocaine Use - 7
Phase 1Completed - NCT00000215
IV Cocaine Abuse: A Laboratory Model - 4
Phase 2Completed - NCT00000291
Effects of Labetalol on Human Cocaine Use - 8
Phase 2Completed - NCT00000208
Methadone/Buprenorphine Cross-Over Study - 4
Phase 2Completed - NCT00000346
Cognitive Correlates of Substance Abuse - 11
Phase 4Unknown - NCT00000285
Effects of Phenytoin on Cocaine Use in Humans - 2
Phase 1Completed - NCT00000307
Naltrexone as Adjunct in Alcoholic Cocaine Dependent Patients - 4
Phase 2Completed - NCT00000284
Role of Metabolites in Nicotine Dependence (1) - 1
Phase 2Completed - NCT00000292
Acute Withdrawal From Smoked Cocaine - 9
Phase 1Completed - NCT00000336
Selegiline in Outpatient Treatment for Cocaine Dependence - 1
Phase 2Completed - NCT00000282
Pemoline for Cocaine Abuse - 7
Phase 2Completed - NCT00000281
Pharmacotherapy for Schizophrenic Drug Users - 6
Phase 2Completed - NCT00000280
Glutaminergic Agents for Cocaine Abuse - 5
Phase 1Completed - NCT00000309
Serotonin/Dopamine Antagonism of Cocaine Effect: 1 - 1
Phase 2Terminated - NCT00000279
Novel Medications for Opiate Detoxification - 4
Phase 2Completed - NCT00000310
Serotonin/Dopamine Antagonism of Cocaine Effect: 2 - 2
Phase 2Terminated - NCT00000311
Combining Behavioral Treatment With Agonist Maintenance - 1
Phase 3Completed - NCT00000293
Effect of Nefazodone on Relapse in Females With Cocaine Abuse - 10
Phase 3Completed - NCT00000312
Alterations in Serotonergic Functions in Cocaine Addicts - 1
Phase 1Completed - NCT00000294
Effects of Carvedilol on Cocaine Use in Humans - 11
Phase 2Completed - NCT00000313
Predictive Values of Serotonergic Alterations for Outcome - 2
Phase 1Terminated - NCT00000278
Disulfiram for Cocaine-Alcohol Abuse - 3
Phase 2Completed - NCT00000277
Mazindol for Cocaine Abuse - 2
Phase 2Completed - NCT00000314
M-CPP and Fenfluramine in Cocaine Addicts - 3
Phase 2Completed - NCT00000331
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-3 - 6
Phase 2Withdrawn - NCT00000295
Progesterone Treatment in Female Smokers - 12
Phase 2Completed - NCT00000276
Dopamine Reuptake Inhibitors of Cocaine Abuse - 1
Phase 1Terminated - NCT00000212
IV Cocaine Abuse: A Laboratory Model - 1
Phase 2Completed - NCT00000275
Cocaine Abuse and ADHD - 10
Phase 2Completed - NCT00000271
New Approaches to Cocaine Abuse Medications (A) - 6
Phase 2Completed - NCT00000274
Flupenthixol and Haloperidol for Treating Cocaine Abuse Schizophrenics - 9
Phase 2Completed - NCT00000273
A Laboratory Model for Heroin Abuse Medications - 8
Phase 2Completed - NCT00000270
Brain Imaging: Cocaine Effects & Medication Development - 5
Phase 4Withdrawn - NCT00000269
Pergolide Treatment for Substance Abusers - 4
Phase 2Completed - NCT00000315
Human Dopamine Transported Imaging in Cocaine Abuse: 1 - 1
Phase 1Completed - NCT00000268
Cocaine Abuse and Attention Deficit Disorder - 3
Not ApplicableCompleted - NCT00000267
Risperidone Treatment in Dually-Diagnosed Individuals - 2
Phase 2Completed - NCT00000259
Sevoflurane vs Nitrous Oxide Inhalation at Subanesthetic Concentrations - 11
Not ApplicableCompleted - NCT00000255
Differential Acute Tolerance Development to Effects of Nitrous Oxide - 7
Phase 2Completed - NCT00000317
Early Phase II Trials for Cocaine Medication Development - 1
Phase 2Completed - NCT00000261
Effects of Alcohol History on Effects of Sevoflurane and Nitrous Oxide - 13
Phase 2Completed - NCT00004640
"Clinical Trials to Enhance Elders' Oral Health" ("TEETH")
Phase 3Completed - NCT00004639
Cleft Palate Surgery and Speech Development
Phase 2Completed